Baby formula shortage: Abbott restarts specialty formula production at Michigan plant

STURGIS, Mich. — In its bid to address a nationwide baby formula shortage, Abbott Nutrition restarted production Saturday of select varieties at its Sturgis, Michigan, plant.

>> Read more trending news

According to the company, production of EleCare, a formula for children who struggle to digest other products, is the priority, along with other specialty and metabolic formulas, CNBC reported.

Abbott, the largest baby formula manufacturer in the U.S., said it was resuming production “after meeting initial requirements” that were specified by a May 16 U.S. Food and Drug Administration consent decree.

>> Related: Baby formula: FDA says supply shortage should be eased ‘within days,’ back to normal in ‘few weeks’

According to The Washington Post, Abbott was required to obtain an independent expert to review operations and compliance with the law, among other specifications.

In turn, Abbott said EleCare could be available again around June 20, and the company is working to meet guidelines to resume production of Similac and other formulas, CNBC reported.

“We understand the urgent need for formula, and our top priority is getting high-quality, safe formula into the hands of families across America,” an Abbott spokesperson said in a prepared statement. “We will ramp production as quickly as we can while meeting all requirements.”

>> Related: United Airlines donating flights to ship baby formula from Europe to US

The Sturgis plant was shut down after an FDA inspection in January found “significant operational deficiencies” and a bacterium that could expose babies to a severe foodborne illness, NBC News reported.

Four infants, two of whom died, were hospitalized with bacterial infections from drinking Abbott’s powdered formula, CNBC reported.

Abbott said its own investigation found “no evidence” linking the formula the plant produced to any illness, but the company did make corrections on “a number of issues,” NBC News reported.

According to the Post, four major companies control 90% of the infant formula supply in the United States: Abbott, Gerber, Mead Johnson and Perrigo Nutritionals.

Previous coverage:

Baby formula shortage: Biden announces steps to help lessen supply chain issues

Baby formula maker Abbott reaches agreement to restart largest production plant

Why is there a baby formula shortage; what can parents do?

Baby formula shortage: What parents need to know

Baby formula shortage: FDA approves plan to release some Abbott-produced formula

Baby formula shortage worsens, nearly 30% of popular brands sold out

Recall alert: More Similac baby formula added to recall list

American Academy of Pediatrics offer new guidance for parents who can’t get formula

FDA closes investigation into contaminated powdered infant formula produced by Abbott Nutrition